Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From 3M
Abbott plans to deliver 30 million BinaxNOW prescription, at-home rapid tests in the first quarter of 2021; 90 million more in the second quarter.
A panel of experts, including the CEO of Roche Diagnostics, discussed how the pandemic will lead to a ”reimagining” of diagnostics, expanding access for testing with at-home testing and virtual care.
After a year like no other for the global medtech industry, 2021 will present a different set of market challenges for device and diagnostic companies.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
- Medical Devices
- OTC, Consumer
- Consumables, Central Supplies
Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
- 3M Company
- Acelity L.P. Inc.
- Crawford Healthcare Holdings Limited
- Kinetic Concepts, Inc.
- Minnesota Mining and Manufacturing
- Scott Safety
- Systagenix Wound Management, Limited